The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical cushing's disease

Endocrine Journal

Volumn 57, Issue 3, 2010, Pages 267-272

  Murakami, Hiroshi ^a   Nigawara, Takeshi ^a   Sakihara, Satoru ^a   Kageyama, Kazunori ^a   Yamashita, Maki ^a   Matsuki, Kota ^a   Tanabe, Jutaro ^a   Matsui, Jun ^a   Tamasawa, Naoki ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Midnight plasma cortisol level; Overnight dexamethasone suppression test; Subclinical cushing's disease; Type 2 diabetes

Indexed keywords

CORTICOTROPIN; DESMOPRESSIN; HYDROCORTISONE;

ADULT; AGED; COMORBIDITY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PREVALENCE;

EID: 77953631119     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-352     Document Type: Note

References (25)

1. Suda T (2002) Adrenal preclinical Cushing's syndrome. Japan Medical Association Journal 45: 172-174.
2. Takao T, Mimoto T, Yamamoto M, Hashimoto K (2001) Preclinical Cushing disease. Arch Intern Med 161: 892-3.
3. Boscaro M, Barzon L, Fallo F, Sonino N (2001) Cushing's syndrome. Lancet 357: 783-91.
4. Howlett TA, Rees LH, Besser GM. (1985) Cushing's syndrome. Clin Endocrinol Metab 14: 911-45.
5. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G (2002) Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87: 4872-4878.
6. Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B, Salvetti A (2003) Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148: 213-219.
7. Reincke M. (2000) Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am. 29: 43-56.
8. Reincke M, Allolio B, Saeger W, Kaulen D, Winkelmann W (1987) A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. J Clin Endocrinol Metab 65: 1296-300.
9. Sakai K, Horiba N, Sakai Y, Hizuka N, Suda T, Kuwayama A, Demura H (1994) A case of preclinical Cushing's disease only accompanied by obesity and glucose intolerance. Folia Endocrinol Jpn 70: 726 (Abstract) (In Japanese).
10. Nagai T, Imamura M, Misumi S, Mori M (2002) Subclinical Cushing's disease accompanied by malignant hypertension and diabetes mellitus. Intern Med 41: 566-70.
11. Ohmori N, Nomura K, Ohmori K, Takano K (2007) Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy. Endocr J 54: 391-7.
12. Kageyama K, Moriyama T, Sakihara S, Kawashima S, Suda T (2003) A case of preclinical Cushing's disease, accompanied with thyroid papillary carcinoma and adrenal incidentaloma. Endocr J 50: 325-31.
13. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ (1996) Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 44: 717-722.
14. Catargi B; Rigalleau V; Poussin A; Ronci-Chaix N; Bex V; Vergnot V; Gin H; Roger P; Tabarin (2003) Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 88: 5808-5813.
15. Suda T, Hashimoto K, Hirata Y, Yokoyama T (2004) A survey of sub(pre)-clinical Cushing's disease and silent corticotroph adenoma in Japan. In Tihara K (ed) Annual report of the research committee for the hypothalamic and pituitary diseases, research on measures for intractable diseases by the Ministry for Health, Labor, and Welfare in Japan: 63-69. (In Japanese).
16. Nawata H, Demura H, Suda T, Takayanagi R (1996) Preclinical Cushing's syndrome. Annual report of the Ministry of Health and Welfare "Disorders of Adrenal Hormones" (Nawata, Ed.) 223 (In Japanese).
17. Oki Y, Hashimoto K, Hirata Y, Iwasaki Y, Nigawara T, Doi M, Sakihara S, Kageyama K, Suda T (2009) Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing's syndrome. Endocr J 56: 897-904.
18. Taniguchi T, Hamasaki A, Okamoto M (2008). Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus. Endocr J 55: 429-32.
19. Viardot A, Huber P, Puder JJ, Zulewski H, Keller U, Muller B (2005) Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J Clin Endocrinol Metab 90: 5730-5736.
20. Aardal E, Holm AC (1995) Cortisol in saliva-reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem 33: 927-32.
21. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93: 1526-40.
22. Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK (1993) Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo- Cushing's states. JAMA 269: 2232-8.
23. Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G, Trischitta V (2005) Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol 153: 837-844.
24. Testa RM, Albiger N, Occhi G, Sanguin F, Scanarini M, Berlucchi S, Gardiman MP, Carollo C, Mantero F, Scaroni C. (2007) The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging. Eur J Endocrinol 156: 241-248.
25. Furgal-Borzych A, Lis GJ, Litwin JA, Rzepecka-Wozniak E, Trela F, Cichocki T. (2007) Increased incidence of pituitary microadenomas in suicide victims. Neuropsychobiology 55: 163-166.